Gout in the Foot and Ankle: Acute Flare Management and Long-Term Treatment

Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

▶ Watch

Gout — the most common inflammatory arthropathy in adults — preferentially targets the first metatarsophalangeal (MTP) joint, causing the classic acute attack of podagra: severe, sudden-onset joint pain reaching maximum intensity within 6–12 hours, with intense redness, warmth, and swelling that makes even bedsheet contact exquisitely painful. Despite its dramatic presentation, gout is a metabolic disease with established urate-lowering therapies that can achieve complete disease control when properly managed.

Pathophysiology of Urate Crystal Deposition

Gout results from chronic hyperuricemia — serum uric acid above 6.8mg/dL at physiologic temperature — which causes monosodium urate (MSU) crystal supersaturation and deposition in synovial fluid and periarticular tissues. The first MTP joint is preferentially affected due to lower peripheral temperature favoring crystal nucleation, dependent position facilitating crystal accumulation, and high mechanical stress promoting synovial microtrauma. Acute gout attacks are triggered by rapid serum urate fluctuations (both increases from dietary purine loading and decreases from urate-lowering therapy initiation) rather than the absolute urate level.

Acute Gout Flare Management

The three first-line therapies for acute gout flares are: (1) NSAIDs (indomethacin 50mg TID or naproxen 500mg BID for 5–7 days) — effective and preferred when renal function and GI history permit; (2) colchicine (1.2mg loading dose followed by 0.6mg one hour later, then 0.6mg BID for 7–10 days) — highly effective when initiated within 24 hours of flare onset; and (3) corticosteroids (oral prednisone 35–50mg/day tapering over 5 days, or intra-articular injection) — appropriate when NSAIDs and colchicine are contraindicated. Intra-articular corticosteroid injection under ultrasound guidance provides rapid, targeted relief for first MTP gout attacks with minimal systemic exposure — particularly useful in patients with renal insufficiency or NSAID contraindications.

Long-Term Urate-Lowering Therapy

Urate-lowering therapy (ULT) is indicated for patients with two or more gout flares per year, tophi, uric acid nephrolithiasis, or chronic gouty arthropathy. The treat-to-target approach — maintaining serum uric acid below 6mg/dL (below 5mg/dL for patients with tophi) — produces progressive dissolution of existing urate crystal deposits and prevents new flare formation. Allopurinol (50–900mg/day) is first-line ULT; febuxostat (40–120mg/day) is an alternative for allopurinol-intolerant patients. ULT initiation should be deferred until the acute flare resolves and then begun gradually with concomitant colchicine prophylaxis (0.6mg daily for 3–6 months) to prevent mobilization flares.

Dietary and Lifestyle Modifications

Dietary modification reduces serum uric acid by 1–2mg/dL — a meaningful but insufficient intervention in most patients without concurrent ULT. High-purine foods to minimize include: red meat, organ meats, shellfish, and high-fructose corn syrup beverages (particularly soft drinks and fruit juices). Beer has disproportionate urate-raising effects beyond its purine content. Daily low-fat dairy consumption, cherries, and adequate hydration have demonstrated modest urate-lowering effects in controlled studies.

Gout Management at Balance Foot & Ankle

Dr. Biernacki at Balance Foot & Ankle diagnoses gout with on-site joint aspiration and polarized light microscopy (MSU crystal identification) and provides intra-articular corticosteroid injection for acute flare management at the first visit. Long-term ULT management coordination and dietary counseling are available. Call (810) 206-1402 — acute gout attacks qualify for same-day emergency evaluation.

Gout Foot & Ankle Treatment in Michigan

Gout attacks in the feet are excruciatingly painful and can cause permanent joint damage without proper management. Our podiatrists provide acute flare treatment and coordinate long-term urate-lowering therapy to prevent recurring attacks.

Get Immediate Gout Relief → | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Dalbeth N, et al. “Gout.” The Lancet. 2021;397(10287):1843-1855.
2. FitzGerald JD, et al. “2020 American College of Rheumatology Guideline for Management of Gout.” Arthritis Care & Research. 2020;72(6):744-760.
3. Richette P, et al. “2016 Updated EULAR Evidence-Based Recommendations for the Management of Gout.” Annals of the Rheumatic Diseases. 2017;76(1):29-42.

Your Board-Certified Podiatrists

Dr. Tom Biernacki, DPM

Board-Certified · FACFAS

Dr. Carl Jay, DPM

Board-Certified Podiatrist

Dr. Daria Gutkin, DPM

Podiatrist

More Podiatrist-Recommended Gout Essentials

Wide-Toe-Box Walking Shoe

No products found.

Eliminates the toe-joint pressure that triggers gout flares.

Cushioned Arch Support

No products found.

Reduces painful big-toe joint loading during active flares.

Metatarsal Pad

No products found.

Offloads the first MTP joint where gout most commonly strikes.

As an Amazon Associate, Balance Foot & Ankle earns from qualifying purchases. Product recommendations are based on clinical experience; prices and availability shown above update live from Amazon.

When to See a Podiatrist

Untreated gout flares cause permanent joint erosion. Balance Foot & Ankle checks uric acid levels, prescribes allopurinol or febuxostat for chronic prevention, and drains the joint for immediate flare relief. Don’t just ice and ibuprofen through attacks — get on a prevention protocol that stops them for good.

Call Balance Foot & Ankle: (810) 206-1402  ·  Book online  ·  Offices in Howell & Bloomfield Hills

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.